GLP-1 Receptor Agonist [EPC]

13 drugs in this class with 1,172,738 total adverse event reports.

13 Drugs
1,172,738 Total Reports
541,371 Serious Reports
57,720 Death Reports
# Drug Name Generic Name Reports Serious Deaths
1 Metformin METFORMIN 348,087 129,185 29,280
2 Insulin Glargine INSULIN GLARGINE 240,130 78,659 13,381
3 Tirzepatide TIRZEPATIDE 140,435 140,069 775
4 Dulaglutide DULAGLUTIDE 86,770 38,675 1,632
5 Semaglutide SEMAGLUTIDE 76,509 66,856 1,333
6 Empagliflozin EMPAGLIFLOZIN 64,248 33,612 3,196
7 Exenatide EXENATIDE 52,309 2,422 1,762
8 Liraglutide LIRAGLUTIDE 48,670 10,336 1,755
9 Insulin Detemir INSULIN DETEMIR 38,855 8,773 2,544
10 Canagliflozin CANAGLIFLOZIN 29,639 3,366 682
11 Insulin Degludec INSULIN DEGLUDEC 22,571 11,400 1,236
12 Bimekizumab BIMEKIZUMAB 16,071 13,341 116
13 Naltrexone Hydrochloride / Bupropion Hydrochloride NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE 8,444 4,677 28